Motif ID: Esr2
Z-value: 2.353
Transcription factors associated with Esr2:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Esr2 | ENSMUSG00000021055.7 | Esr2 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Esr2 | mm10_v2_chr12_-_76177251_76177265 | -0.27 | 1.9e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.1 | 30.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 5.9 | 17.8 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
| 5.2 | 15.5 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 4.7 | 14.1 | GO:0032430 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) positive regulation of phospholipase A2 activity(GO:0032430) |
| 3.8 | 15.3 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 3.7 | 3.7 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 3.7 | 11.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 3.2 | 9.6 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 3.0 | 6.1 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 3.0 | 8.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 2.9 | 8.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 2.9 | 8.6 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 2.6 | 13.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 2.6 | 5.1 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 2.5 | 17.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 2.5 | 27.2 | GO:0097421 | liver regeneration(GO:0097421) |
| 2.3 | 16.1 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 2.2 | 13.1 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 2.1 | 2.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 2.1 | 6.2 | GO:0015747 | urate transport(GO:0015747) |
| 2.0 | 6.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 2.0 | 12.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 2.0 | 2.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
| 2.0 | 7.9 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.9 | 1.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.9 | 5.7 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) regulation of bleb assembly(GO:1904170) |
| 1.9 | 7.4 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 1.8 | 3.7 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 1.8 | 5.5 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 1.8 | 5.5 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 1.8 | 5.5 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 1.8 | 9.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 1.8 | 5.4 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 1.8 | 10.7 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 1.8 | 7.0 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 1.8 | 8.8 | GO:0070459 | prolactin secretion(GO:0070459) |
| 1.7 | 1.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 1.7 | 5.1 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 1.7 | 5.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 1.7 | 5.0 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
| 1.7 | 9.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.6 | 1.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 1.6 | 8.1 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 1.6 | 3.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 1.6 | 4.8 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 1.6 | 6.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 1.5 | 12.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 1.5 | 4.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 1.5 | 1.5 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 1.5 | 4.5 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 1.5 | 5.9 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.5 | 19.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 1.4 | 7.2 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 1.4 | 4.3 | GO:0008272 | sulfate transport(GO:0008272) |
| 1.4 | 10.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.4 | 6.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
| 1.4 | 2.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.4 | 5.4 | GO:0090472 | dibasic protein processing(GO:0090472) |
| 1.4 | 8.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 1.3 | 5.4 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
| 1.3 | 5.3 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 1.3 | 8.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 1.3 | 1.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 1.3 | 6.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 1.3 | 10.5 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 1.3 | 3.9 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) negative regulation of lymphocyte migration(GO:2000402) regulation of natural killer cell chemotaxis(GO:2000501) |
| 1.3 | 3.9 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 1.3 | 5.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 1.3 | 3.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 1.3 | 3.8 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 1.3 | 5.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 1.3 | 1.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 1.2 | 3.7 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 1.2 | 2.5 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.2 | 1.2 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.2 | 4.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.2 | 2.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 1.2 | 7.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 1.2 | 6.1 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 1.2 | 4.8 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.2 | 4.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 1.2 | 1.2 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
| 1.2 | 8.3 | GO:0033227 | dsRNA transport(GO:0033227) |
| 1.2 | 8.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 1.2 | 3.5 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 1.2 | 1.2 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 1.2 | 3.5 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 1.2 | 3.5 | GO:0046032 | ADP catabolic process(GO:0046032) |
| 1.2 | 2.3 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 1.1 | 4.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 1.1 | 1.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 1.1 | 3.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 1.1 | 4.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 1.1 | 4.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 1.1 | 16.4 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 1.1 | 5.5 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.1 | 3.3 | GO:0036166 | phenotypic switching(GO:0036166) |
| 1.1 | 4.4 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 1.1 | 9.8 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) |
| 1.1 | 4.3 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 1.1 | 3.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.1 | 2.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 1.1 | 4.3 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 1.1 | 2.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 1.1 | 14.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 1.1 | 1.1 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) |
| 1.1 | 3.2 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 1.1 | 2.1 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
| 1.1 | 1.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 1.0 | 4.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
| 1.0 | 3.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 1.0 | 3.1 | GO:0030421 | defecation(GO:0030421) |
| 1.0 | 3.1 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
| 1.0 | 6.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 1.0 | 6.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 1.0 | 4.0 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 1.0 | 11.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 1.0 | 3.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 1.0 | 2.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 1.0 | 2.9 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.0 | 3.9 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 1.0 | 3.9 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 1.0 | 3.9 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 1.0 | 2.9 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 1.0 | 5.8 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.9 | 3.8 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.9 | 3.8 | GO:0035989 | tendon development(GO:0035989) |
| 0.9 | 1.9 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
| 0.9 | 4.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.9 | 2.7 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.9 | 4.5 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.9 | 3.6 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.9 | 2.7 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.9 | 10.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.9 | 0.9 | GO:1904809 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.9 | 2.6 | GO:1902460 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.9 | 1.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.8 | 4.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.8 | 5.0 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.8 | 2.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.8 | 5.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.8 | 2.5 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.8 | 5.0 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.8 | 1.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.8 | 9.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.8 | 4.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.8 | 4.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.8 | 7.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.8 | 2.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.8 | 3.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.8 | 5.6 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.8 | 3.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.8 | 2.4 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.8 | 2.4 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.8 | 3.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.8 | 1.6 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.8 | 2.3 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.8 | 2.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.8 | 3.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.8 | 2.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.8 | 5.4 | GO:0015862 | uridine transport(GO:0015862) |
| 0.8 | 0.8 | GO:0003195 | tricuspid valve formation(GO:0003195) |
| 0.8 | 2.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.8 | 2.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.8 | 8.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.8 | 0.8 | GO:0042368 | negative regulation of vitamin D biosynthetic process(GO:0010957) vitamin D biosynthetic process(GO:0042368) negative regulation of vitamin metabolic process(GO:0046137) regulation of vitamin D biosynthetic process(GO:0060556) |
| 0.8 | 3.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.8 | 0.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.8 | 3.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
| 0.8 | 3.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.8 | 3.1 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.8 | 1.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.8 | 2.3 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.8 | 4.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.7 | 3.0 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.7 | 5.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.7 | 3.0 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.7 | 3.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.7 | 2.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 0.7 | 3.0 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.7 | 0.7 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
| 0.7 | 6.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.7 | 4.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.7 | 10.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.7 | 2.9 | GO:0015871 | choline transport(GO:0015871) |
| 0.7 | 0.7 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 0.7 | 1.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.7 | 3.6 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.7 | 7.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.7 | 3.6 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.7 | 7.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.7 | 6.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.7 | 2.8 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.7 | 3.5 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.7 | 7.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.7 | 3.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.7 | 13.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.7 | 4.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.7 | 2.8 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.7 | 6.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.7 | 5.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.7 | 1.4 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.7 | 0.7 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
| 0.7 | 2.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 0.7 | 2.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.7 | 2.0 | GO:0019043 | establishment of viral latency(GO:0019043) |
| 0.7 | 4.1 | GO:1902988 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.7 | 1.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.7 | 2.7 | GO:0042637 | catagen(GO:0042637) |
| 0.7 | 1.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.7 | 7.2 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
| 0.7 | 3.9 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.6 | 3.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.6 | 9.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.6 | 1.9 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.6 | 3.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.6 | 1.9 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.6 | 2.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.6 | 3.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.6 | 1.9 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 0.6 | 6.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.6 | 3.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.6 | 2.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.6 | 1.8 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 0.6 | 2.5 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
| 0.6 | 3.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.6 | 2.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.6 | 1.8 | GO:0006296 | base-excision repair, AP site formation(GO:0006285) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.6 | 4.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.6 | 4.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.6 | 1.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.6 | 21.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.6 | 1.8 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.6 | 3.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.6 | 0.6 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.6 | 1.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.6 | 1.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.6 | 1.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.6 | 6.5 | GO:0015816 | glycine transport(GO:0015816) |
| 0.6 | 5.3 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.6 | 1.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.6 | 1.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.6 | 0.6 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.6 | 2.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
| 0.6 | 1.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
| 0.6 | 1.7 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.6 | 3.5 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.6 | 4.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.6 | 2.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.6 | 4.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.6 | 2.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.6 | 14.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.6 | 0.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.6 | 3.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.6 | 2.8 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.6 | 3.9 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.6 | 7.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.6 | 1.1 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.6 | 1.7 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.6 | 2.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.6 | 9.4 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.5 | 3.8 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 0.5 | 7.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.5 | 3.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.5 | 2.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.5 | 1.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.5 | 3.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.5 | 2.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.5 | 1.6 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.5 | 1.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.5 | 1.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.5 | 3.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.5 | 1.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.5 | 1.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.5 | 6.8 | GO:0042407 | cristae formation(GO:0042407) |
| 0.5 | 2.6 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.5 | 2.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.5 | 5.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.5 | 1.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.5 | 2.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 0.5 | 1.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.5 | 1.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.5 | 1.0 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.5 | 2.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.5 | 0.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.5 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
| 0.5 | 2.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.5 | 3.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.5 | 2.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.5 | 7.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.5 | 14.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.5 | 1.5 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.5 | 6.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.5 | 5.9 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.5 | 0.5 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.5 | 2.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.5 | 2.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.5 | 1.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.5 | 1.9 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.5 | 2.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.5 | 2.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.5 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.5 | 3.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.5 | 1.4 | GO:1901727 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.5 | 2.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.5 | 6.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.5 | 1.9 | GO:0048069 | eye pigmentation(GO:0048069) |
| 0.5 | 1.9 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.5 | 3.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.5 | 6.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.5 | 2.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.5 | 0.9 | GO:1902022 | L-lysine transport(GO:1902022) |
| 0.5 | 1.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.5 | 6.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.5 | 1.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.5 | 2.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.5 | 0.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.4 | 5.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.4 | 0.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.4 | 3.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.4 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.4 | 1.3 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.4 | 1.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.4 | 0.9 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.4 | 4.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.4 | 0.9 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.4 | 8.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.4 | 0.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.4 | 7.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.4 | 1.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
| 0.4 | 1.3 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.4 | 1.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
| 0.4 | 1.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.4 | 4.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.4 | 3.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 1.7 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.4 | 1.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.4 | 3.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.4 | 2.5 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.4 | 0.8 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.4 | 3.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 | 0.8 | GO:0021586 | pons maturation(GO:0021586) |
| 0.4 | 1.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.4 | 0.8 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.4 | 0.8 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.4 | 0.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.4 | 4.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.4 | 5.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.4 | 2.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.4 | 3.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.4 | 0.4 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.4 | 2.5 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.4 | 0.8 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.4 | 7.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.4 | 0.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.4 | 3.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.4 | 1.2 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.4 | 9.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.4 | 1.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.4 | 4.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.4 | 0.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.4 | 0.8 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.4 | 1.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.4 | 0.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.4 | 1.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.4 | 1.6 | GO:0097501 | stress response to metal ion(GO:0097501) |
| 0.4 | 0.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.4 | 0.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 | 1.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.4 | 3.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 | 0.8 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) ERK5 cascade(GO:0070375) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.4 | 1.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.4 | 1.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.4 | 1.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.4 | 1.9 | GO:0070627 | ferrous iron import(GO:0070627) |
| 0.4 | 4.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.4 | 1.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 | 1.1 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
| 0.4 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.4 | 2.7 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.4 | 1.5 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.4 | 1.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 | 5.7 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.4 | 3.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.4 | 6.0 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.4 | 1.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 10.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.4 | 1.5 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.4 | 3.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.4 | 6.0 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.4 | 1.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.4 | 1.5 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
| 0.4 | 1.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.4 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.4 | 0.7 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.4 | 2.2 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.4 | 0.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.4 | 0.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.4 | 1.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 | 1.8 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.4 | 6.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.4 | 4.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.4 | 6.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.4 | 1.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.4 | 1.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.4 | 2.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.4 | 0.7 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.4 | 2.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.4 | 3.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.4 | 1.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 | 1.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.4 | 0.4 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
| 0.4 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.4 | 1.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 | 1.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
| 0.4 | 1.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.3 | 3.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.3 | 4.2 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.3 | 3.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 | 4.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.3 | 3.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.3 | 1.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.3 | 3.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.3 | 1.0 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.3 | 3.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.3 | 1.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
| 0.3 | 1.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 | 2.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 4.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.3 | 2.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.3 | 1.4 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.3 | 6.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.3 | 4.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.3 | 1.3 | GO:0006563 | L-serine metabolic process(GO:0006563) |
| 0.3 | 1.3 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.3 | 0.7 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) positive regulation of gonadotropin secretion(GO:0032278) |
| 0.3 | 5.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.3 | 3.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
| 0.3 | 3.3 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.3 | 0.7 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
| 0.3 | 1.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.3 | 1.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.3 | 4.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.3 | 2.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.3 | 3.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.3 | 1.3 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
| 0.3 | 1.3 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.3 | 1.0 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.3 | 1.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.3 | 0.6 | GO:0051608 | histamine transport(GO:0051608) |
| 0.3 | 2.6 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.3 | 2.2 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.3 | 4.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
| 0.3 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 2.8 | GO:0043084 | penile erection(GO:0043084) |
| 0.3 | 5.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.3 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.3 | 1.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.3 | 0.9 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.3 | 1.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.3 | 2.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.3 | 2.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.3 | 3.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.3 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 | 3.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.3 | 1.5 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.3 | 1.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.3 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.3 | 2.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 2.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.3 | 2.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 | 1.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.3 | 0.3 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.3 | 1.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.3 | 4.1 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.3 | 1.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.3 | 2.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 | 1.5 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.3 | 2.6 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.3 | 1.5 | GO:0043312 | neutrophil degranulation(GO:0043312) |
| 0.3 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
| 0.3 | 1.7 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.3 | 3.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 | 1.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 0.9 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.3 | 1.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 0.9 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.3 | 4.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.3 | 2.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.3 | 3.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 | 1.7 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.3 | 4.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.3 | 1.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.3 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 | 2.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 0.3 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.3 | 2.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.3 | 2.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.3 | 1.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.3 | 2.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 | 0.8 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 | 2.5 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.3 | 1.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.3 | 2.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.3 | 0.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.3 | 1.6 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.3 | 2.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.3 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 0.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 | 1.3 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.3 | 1.6 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.3 | 1.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.3 | 3.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.3 | 0.3 | GO:0033865 | coenzyme A metabolic process(GO:0015936) nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
| 0.3 | 1.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.3 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 5.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.3 | 1.6 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.3 | 2.4 | GO:0007351 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.3 | 0.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.3 | 0.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.3 | 1.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.3 | 7.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.3 | 0.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.3 | 0.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 0.3 | 1.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.3 | 2.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.3 | 2.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.3 | 13.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.3 | 1.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.3 | 1.5 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.3 | 1.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.3 | 2.3 | GO:0043482 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.3 | 1.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.3 | 2.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.3 | 2.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.3 | 3.0 | GO:0015809 | arginine transport(GO:0015809) |
| 0.3 | 0.5 | GO:0071673 | monocyte extravasation(GO:0035696) positive regulation of smooth muscle cell chemotaxis(GO:0071673) regulation of monocyte extravasation(GO:2000437) |
| 0.3 | 0.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 | 1.0 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.3 | 0.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 | 2.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 2.3 | GO:0001553 | luteinization(GO:0001553) |
| 0.2 | 3.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 4.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.2 | 5.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.2 | 1.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.2 | 2.2 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.2 | 1.0 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.2 | 1.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.2 | 0.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.2 | 1.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.2 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 | 0.7 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.2 | 5.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.2 | 1.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.2 | 1.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 | 4.1 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.2 | 0.7 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.2 | 2.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.2 | 1.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.2 | 3.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.2 | 0.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 | 2.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
| 0.2 | 0.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 | 7.9 | GO:0006414 | translational elongation(GO:0006414) |
| 0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 2.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
| 0.2 | 2.8 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.2 | 5.3 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.2 | 0.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.2 | 2.1 | GO:0072078 | nephron tubule morphogenesis(GO:0072078) nephron epithelium morphogenesis(GO:0072088) |
| 0.2 | 0.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 0.2 | 0.9 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.2 | 0.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.2 | 0.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.2 | 1.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 | 1.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 | 1.4 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.2 | 2.7 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 | 1.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.2 | 1.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 | 2.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 2.0 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.2 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
| 0.2 | 1.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 | 6.2 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.2 | 1.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.2 | 1.5 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.2 | 1.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 | 1.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 | 1.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 | 0.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 1.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
| 0.2 | 3.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
| 0.2 | 1.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 | 0.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.2 | 3.8 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.2 | 1.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.2 | 2.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.2 | 1.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 1.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.2 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 4.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.2 | 1.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.2 | 2.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.2 | 2.2 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.2 | 1.0 | GO:0010675 | regulation of cellular carbohydrate metabolic process(GO:0010675) |
| 0.2 | 2.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.2 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.2 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 1.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.2 | 0.8 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
| 0.2 | 1.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 0.6 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.2 | 0.6 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.2 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.2 | 1.0 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.2 | 3.3 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.2 | 2.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.2 | 1.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 0.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 0.4 | GO:0015817 | histidine transport(GO:0015817) |
| 0.2 | 1.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 1.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 | 1.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.2 | 0.6 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.2 | 1.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.2 | 0.6 | GO:1901421 | generation of catalytic spliceosome for second transesterification step(GO:0000350) positive regulation of response to alcohol(GO:1901421) |
| 0.2 | 0.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.2 | 1.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 | 5.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.2 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 | 0.5 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 1.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.2 | 3.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.2 | 1.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 2.0 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.2 | 5.1 | GO:0051384 | response to glucocorticoid(GO:0051384) |
| 0.2 | 1.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.2 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
| 0.2 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.2 | 1.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
| 0.2 | 2.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.2 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.2 | 3.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.2 | 1.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 | 1.0 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.2 | 1.2 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.2 | 1.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.2 | 0.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.2 | 0.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.2 | 0.8 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.2 | 0.8 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.2 | 7.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.2 | 2.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.2 | 0.3 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
| 0.2 | 1.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.2 | 1.4 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.2 | 1.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.8 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.2 | 0.9 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.2 | 2.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.2 | 0.3 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.2 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.2 | 1.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.2 | 0.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 2.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.2 | 0.5 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 | 2.9 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 | 2.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.2 | 0.6 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 1.7 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.2 | 1.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 | 0.1 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.1 | 0.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 0.1 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 0.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.1 | 2.6 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 | 0.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 0.9 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 | 3.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.1 | 1.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.3 | GO:0072210 | metanephric nephron development(GO:0072210) |
| 0.1 | 0.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 | 0.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.1 | 1.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.1 | 0.7 | GO:0007128 | M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) |
| 0.1 | 1.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.1 | 0.9 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.1 | 0.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 | 0.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.1 | 1.7 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
| 0.1 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.6 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.1 | 1.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.1 | 0.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
| 0.1 | 5.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.1 | 1.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.1 | 1.6 | GO:0006818 | hydrogen transport(GO:0006818) |
| 0.1 | 5.1 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.1 | 2.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.1 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.1 | 0.7 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 1.0 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 | 2.0 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 | 1.7 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 0.3 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.1 | 1.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 | 2.9 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.1 | 0.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
| 0.1 | 0.4 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 | 0.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 2.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 2.4 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.7 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 | 0.6 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.1 | 0.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 0.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.1 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 | 1.1 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 1.1 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 1.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 2.0 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 1.7 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 | 0.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 5.7 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.1 | 1.6 | GO:0032355 | response to estradiol(GO:0032355) |
| 0.1 | 3.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 1.5 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.1 | 1.3 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.1 | 0.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.1 | 1.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 0.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) respiratory burst involved in defense response(GO:0002679) |
| 0.1 | 0.7 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.1 | 0.2 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 | 0.4 | GO:0042891 | antibiotic transport(GO:0042891) |
| 0.1 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.1 | 0.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.1 | 0.9 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 0.4 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) multi-organism localization(GO:1902579) |
| 0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 1.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.1 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 0.6 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.1 | 0.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.1 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 2.9 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.1 | 1.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 0.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.1 | 0.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.5 | GO:0019882 | antigen processing and presentation(GO:0019882) |
| 0.1 | 2.2 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
| 0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 | 0.8 | GO:0045056 | transcytosis(GO:0045056) |
| 0.1 | 1.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 1.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.1 | 0.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 | 0.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 3.3 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.1 | 0.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
| 0.1 | 1.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.1 | 0.9 | GO:0022602 | ovulation cycle process(GO:0022602) |
| 0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 4.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 0.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.1 | 1.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.1 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.1 | 0.6 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 1.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.1 | 0.6 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
| 0.1 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 0.1 | 1.9 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.1 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 1.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 | 0.8 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
| 0.1 | 0.7 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
| 0.1 | 0.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 | 0.4 | GO:0031034 | myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 | 2.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 1.6 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 | 0.9 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 0.9 | GO:0000305 | response to oxygen radical(GO:0000305) |
| 0.1 | 0.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 2.0 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.1 | 0.1 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
| 0.1 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.3 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
| 0.1 | 1.3 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 | 0.2 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.1 | 0.6 | GO:0009409 | response to cold(GO:0009409) |
| 0.1 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 0.2 | GO:0015786 | UDP-glucose transport(GO:0015786) |
| 0.1 | 1.1 | GO:0008217 | regulation of blood pressure(GO:0008217) |
| 0.1 | 0.2 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 | 0.6 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
| 0.1 | 0.9 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 1.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.1 | 1.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 1.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 1.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 1.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.0 | 1.1 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
| 0.0 | 0.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 | 0.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.0 | 0.5 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.0 | 0.5 | GO:0097530 | granulocyte migration(GO:0097530) |
| 0.0 | 0.1 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.0 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
| 0.0 | 0.2 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
| 0.0 | 2.9 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.0 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.0 | 0.8 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.0 | 0.2 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 | 0.6 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
| 0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.0 | 0.2 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 | 0.1 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.6 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
| 0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.0 | 0.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.0 | 0.1 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.0 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 | 0.2 | GO:0009615 | response to virus(GO:0009615) |
| 0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 | 1.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 0.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
| 0.0 | 0.1 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.0 | 0.6 | GO:0007601 | visual perception(GO:0007601) |
| 0.0 | 0.2 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.0 | 0.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.0 | 17.9 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 5.9 | 17.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 5.4 | 21.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 4.5 | 27.3 | GO:0005796 | Golgi lumen(GO:0005796) |
| 3.7 | 3.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 2.5 | 2.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 2.4 | 9.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 2.3 | 11.7 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 2.3 | 18.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 2.2 | 6.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 2.0 | 24.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 1.8 | 9.0 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.7 | 10.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 1.6 | 9.7 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.5 | 7.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 1.4 | 10.0 | GO:0042825 | TAP complex(GO:0042825) |
| 1.4 | 6.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 1.4 | 5.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 1.3 | 18.8 | GO:0005614 | interstitial matrix(GO:0005614) |
| 1.3 | 3.9 | GO:0005940 | septin ring(GO:0005940) |
| 1.3 | 1.3 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 1.3 | 1.3 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
| 1.3 | 5.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 1.2 | 4.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 1.2 | 9.7 | GO:0001520 | outer dense fiber(GO:0001520) |
| 1.2 | 3.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.2 | 11.9 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 1.2 | 3.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 1.1 | 3.4 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 1.1 | 9.8 | GO:0061574 | ASAP complex(GO:0061574) |
| 1.1 | 9.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 1.1 | 4.3 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
| 1.1 | 6.4 | GO:0071986 | Ragulator complex(GO:0071986) |
| 1.0 | 3.1 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 1.0 | 5.1 | GO:1990745 | EARP complex(GO:1990745) |
| 1.0 | 1.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 1.0 | 2.9 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 0.9 | 3.7 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.9 | 4.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.9 | 3.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.9 | 4.4 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.9 | 3.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.9 | 2.6 | GO:0071438 | integrin alpha3-beta1 complex(GO:0034667) invadopodium membrane(GO:0071438) |
| 0.9 | 13.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.9 | 2.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.9 | 5.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.9 | 5.1 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.8 | 5.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.8 | 2.4 | GO:0043512 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
| 0.8 | 6.5 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.8 | 8.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.8 | 4.0 | GO:0001652 | granular component(GO:0001652) |
| 0.8 | 37.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.8 | 2.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.8 | 2.3 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.8 | 8.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.8 | 8.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.7 | 2.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.7 | 2.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.7 | 9.9 | GO:0043203 | axon hillock(GO:0043203) |
| 0.7 | 5.7 | GO:0042611 | MHC protein complex(GO:0042611) |
| 0.7 | 2.1 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.7 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.7 | 4.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.7 | 10.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.7 | 2.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.7 | 3.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 0.7 | 4.7 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.7 | 1.3 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.7 | 5.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.6 | 3.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.6 | 1.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.6 | 5.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.6 | 6.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.6 | 2.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.6 | 2.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.6 | 5.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.6 | 8.9 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.6 | 3.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.6 | 2.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 0.6 | 4.0 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.6 | 1.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.6 | 2.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.6 | 2.2 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.5 | 3.8 | GO:0005638 | lamin filament(GO:0005638) |
| 0.5 | 2.7 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.5 | 8.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.5 | 4.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.5 | 2.1 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.5 | 3.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.5 | 1.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.5 | 6.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.5 | 3.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.5 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.5 | 3.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.5 | 3.6 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.5 | 1.5 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
| 0.5 | 25.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.5 | 8.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.5 | 4.0 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.5 | 1.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.5 | 15.7 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.5 | 2.0 | GO:0045180 | basal cortex(GO:0045180) |
| 0.5 | 3.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.5 | 3.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.5 | 4.8 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.5 | 15.6 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.5 | 5.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
| 0.5 | 7.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.5 | 4.2 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.5 | 8.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.5 | 2.8 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.5 | 2.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.4 | 3.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 2.7 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.4 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 3.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.4 | 7.7 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
| 0.4 | 1.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.4 | 13.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.4 | 4.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.4 | 3.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.4 | 2.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.4 | 5.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.4 | 2.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.4 | 2.8 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.4 | 1.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.4 | 1.9 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.4 | 1.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.4 | 3.0 | GO:0042581 | specific granule(GO:0042581) |
| 0.4 | 0.8 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.4 | 1.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.4 | 0.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.4 | 0.4 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.4 | 1.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.4 | 1.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.4 | 2.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.4 | 1.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.4 | 21.8 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.4 | 2.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.4 | 2.5 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.3 | 2.4 | GO:0030315 | T-tubule(GO:0030315) |
| 0.3 | 21.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.3 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
| 0.3 | 3.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.3 | 5.7 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.3 | 6.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.3 | 6.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.3 | 1.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) omegasome membrane(GO:1903349) |
| 0.3 | 2.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.3 | 1.6 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.3 | 1.9 | GO:0071203 | WASH complex(GO:0071203) |
| 0.3 | 3.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 1.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.3 | 3.1 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.3 | 0.9 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.3 | 2.4 | GO:0032009 | early phagosome(GO:0032009) |
| 0.3 | 1.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 1.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.3 | 0.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.3 | 21.5 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.3 | 0.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.3 | 2.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.3 | 0.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
| 0.3 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 4.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.3 | 3.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.3 | 0.8 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
| 0.3 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.3 | 4.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.3 | 5.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.3 | 1.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.3 | 0.5 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.3 | 2.6 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.3 | 1.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.3 | 2.9 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.3 | 2.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.3 | 5.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.3 | 4.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.3 | 5.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.3 | 8.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.3 | 1.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
| 0.3 | 0.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.2 | 2.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.2 | 4.8 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.2 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.2 | 1.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.2 | 2.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.2 | 1.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 10.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 3.8 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.2 | 0.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 0.7 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.2 | 1.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 5.4 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.2 | 0.4 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.2 | 2.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.2 | 0.8 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.2 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 0.2 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.2 | 59.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.2 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.2 | 1.8 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 8.1 | GO:0032420 | stereocilium(GO:0032420) |
| 0.2 | 1.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 2.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 2.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 1.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.2 | 2.8 | GO:0042555 | MCM complex(GO:0042555) |
| 0.2 | 2.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 1.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.2 | 2.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.2 | 12.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.2 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 6.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 4.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.2 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.2 | 13.2 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 1.7 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 3.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 0.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.2 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.2 | 12.6 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.2 | 20.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.2 | 4.7 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.2 | 0.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.2 | 7.0 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.2 | 10.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 2.1 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.2 | 2.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 8.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.2 | 51.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.2 | 2.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 1.5 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 5.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.1 | 1.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 2.7 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 3.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 7.2 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 3.1 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.1 | 1.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 1.6 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.1 | 1.4 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.4 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 1.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 4.1 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 3.3 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 42.3 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 2.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 19.3 | GO:0009986 | cell surface(GO:0009986) |
| 0.1 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 4.3 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 2.9 | GO:0005840 | ribosome(GO:0005840) |
| 0.1 | 0.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.1 | 6.0 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 1.4 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
| 0.1 | 0.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 1.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 2.2 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 2.1 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 4.5 | GO:0010008 | endosome membrane(GO:0010008) endosomal part(GO:0044440) |
| 0.1 | 25.6 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 6.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 1.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 4.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.1 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 1.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) SMAD protein complex(GO:0071141) |
| 0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 22.7 | GO:0005768 | endosome(GO:0005768) |
| 0.1 | 2.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 3.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.1 | 0.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 1.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 1.7 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 36.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
| 0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.3 | GO:0044437 | vacuolar part(GO:0044437) |
| 0.1 | 1.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 58.9 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.1 | 1.6 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 1.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 1.1 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 1.4 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
| 0.1 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 26.1 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
| 0.0 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 2.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.0 | 1.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.6 | GO:0030016 | myofibril(GO:0030016) |
| 0.0 | 0.0 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.7 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.3 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.0 | 0.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.0 | 0.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.3 | 29.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 5.9 | 17.8 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 5.4 | 21.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 5.2 | 15.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 4.5 | 13.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 3.7 | 11.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 3.2 | 9.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 3.2 | 9.6 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 2.9 | 8.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 2.4 | 16.7 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 2.3 | 11.7 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 2.3 | 20.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 2.2 | 13.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 2.0 | 30.4 | GO:0046977 | TAP binding(GO:0046977) |
| 1.9 | 11.3 | GO:0019841 | retinol binding(GO:0019841) |
| 1.8 | 5.5 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
| 1.8 | 9.1 | GO:0005534 | galactose binding(GO:0005534) |
| 1.8 | 7.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 1.7 | 7.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 1.7 | 10.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 1.7 | 6.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 1.6 | 9.5 | GO:0019864 | immunoglobulin receptor activity(GO:0019763) IgG binding(GO:0019864) |
| 1.6 | 12.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 1.5 | 33.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 1.5 | 7.6 | GO:0070404 | NADH binding(GO:0070404) |
| 1.5 | 4.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.5 | 3.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 1.5 | 9.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.5 | 4.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 1.5 | 3.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.5 | 5.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 1.4 | 4.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
| 1.4 | 5.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 1.4 | 27.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 1.4 | 4.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 1.4 | 6.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.3 | 17.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 1.3 | 4.0 | GO:0031403 | lithium ion binding(GO:0031403) |
| 1.3 | 4.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 1.3 | 3.9 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.3 | 1.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 1.3 | 3.8 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 1.2 | 12.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 1.2 | 13.4 | GO:0008430 | selenium binding(GO:0008430) |
| 1.2 | 3.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.2 | 15.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 1.2 | 2.4 | GO:0016918 | retinal binding(GO:0016918) |
| 1.2 | 4.6 | GO:0035473 | lipase binding(GO:0035473) |
| 1.1 | 4.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 1.1 | 3.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.1 | 6.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 1.1 | 4.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.1 | 4.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 1.1 | 9.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 1.0 | 3.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 1.0 | 12.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 1.0 | 3.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 1.0 | 2.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 1.0 | 2.9 | GO:0004454 | ketohexokinase activity(GO:0004454) |
| 0.9 | 8.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.9 | 2.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.9 | 8.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.9 | 0.9 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.9 | 9.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.9 | 4.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.9 | 3.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.9 | 2.6 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.9 | 2.6 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
| 0.9 | 0.9 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.9 | 6.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.9 | 5.1 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
| 0.8 | 14.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.8 | 9.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.8 | 1.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.8 | 1.7 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.8 | 2.5 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.8 | 2.5 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.8 | 2.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.8 | 4.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.8 | 5.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.8 | 6.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.8 | 2.4 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
| 0.8 | 2.4 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.8 | 3.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.8 | 18.4 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.8 | 2.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.8 | 3.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.8 | 2.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.8 | 7.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.8 | 2.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.8 | 2.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.8 | 7.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.8 | 3.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.8 | 12.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.8 | 2.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.8 | 3.1 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) lipase inhibitor activity(GO:0055102) |
| 0.8 | 3.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.8 | 1.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.7 | 1.5 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.7 | 1.5 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.7 | 4.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.7 | 3.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
| 0.7 | 11.1 | GO:0005537 | mannose binding(GO:0005537) |
| 0.7 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.7 | 5.1 | GO:0015288 | porin activity(GO:0015288) |
| 0.7 | 2.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.7 | 2.9 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.7 | 5.0 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.7 | 2.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.7 | 4.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.7 | 2.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.7 | 6.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.7 | 2.8 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.7 | 15.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.7 | 1.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.7 | 5.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.7 | 19.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.7 | 3.4 | GO:0016151 | nickel cation binding(GO:0016151) |
| 0.7 | 2.0 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.7 | 1.3 | GO:0098809 | nitrite reductase activity(GO:0098809) |
| 0.7 | 2.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.6 | 0.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.6 | 5.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.6 | 2.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.6 | 1.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.6 | 2.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.6 | 3.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.6 | 7.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.6 | 1.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.6 | 1.9 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.6 | 2.5 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.6 | 2.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.6 | 4.1 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.6 | 12.9 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.6 | 2.9 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.6 | 1.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.6 | 8.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.6 | 1.8 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.6 | 2.3 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.6 | 5.8 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.6 | 4.6 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.6 | 1.7 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
| 0.6 | 4.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.6 | 2.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.6 | 1.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.6 | 5.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.6 | 2.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.6 | 22.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.6 | 3.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.6 | 1.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.6 | 1.7 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.5 | 1.6 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
| 0.5 | 3.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.5 | 1.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.5 | 3.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.5 | 1.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.5 | 3.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.5 | 1.6 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.5 | 3.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.5 | 12.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.5 | 3.1 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.5 | 19.7 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
| 0.5 | 4.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.5 | 2.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.5 | 2.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.5 | 4.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.5 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.5 | 2.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.5 | 2.0 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
| 0.5 | 3.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.5 | 2.5 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.5 | 1.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.5 | 1.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.5 | 5.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.5 | 2.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.5 | 2.9 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.5 | 3.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.5 | 2.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.5 | 1.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.5 | 2.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.5 | 11.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.5 | 2.8 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.5 | 2.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.5 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.5 | 1.8 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.5 | 1.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.5 | 3.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.5 | 1.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.4 | 7.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.4 | 3.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.4 | 1.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.4 | 7.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.4 | 4.0 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
| 0.4 | 2.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.4 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.4 | 1.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.4 | 3.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.4 | 1.7 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.4 | 1.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.4 | 1.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.4 | 0.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.4 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.4 | 5.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.4 | 5.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.4 | 3.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.4 | 1.3 | GO:1901618 | organic hydroxy compound transmembrane transporter activity(GO:1901618) |
| 0.4 | 1.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.4 | 2.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.4 | 13.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.4 | 2.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.4 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.4 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.4 | 15.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.4 | 1.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.4 | 0.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.4 | 7.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.4 | 2.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.4 | 8.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
| 0.4 | 15.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.4 | 5.1 | GO:0031386 | protein tag(GO:0031386) |
| 0.4 | 1.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 0.4 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.4 | 1.5 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 0.4 | 1.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.4 | 5.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.4 | 3.1 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 1.5 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.4 | 5.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.4 | 1.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.4 | 1.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.4 | 0.7 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.4 | 4.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.4 | 4.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.4 | 2.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.4 | 2.6 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.4 | 3.3 | GO:0016595 | glutamate binding(GO:0016595) |
| 0.4 | 0.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.4 | 1.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.4 | 2.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.4 | 10.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.4 | 4.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.3 | 3.1 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.3 | 0.7 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.3 | 1.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.3 | 1.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.3 | 15.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.3 | 3.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.3 | 2.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.3 | 1.0 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 0.3 | 8.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.3 | 8.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.3 | 4.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 1.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.3 | 16.5 | GO:0005179 | hormone activity(GO:0005179) |
| 0.3 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 11.4 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.3 | 1.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.3 | 0.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.3 | 2.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.3 | 1.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.3 | 28.7 | GO:0008201 | heparin binding(GO:0008201) |
| 0.3 | 1.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.3 | 3.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.3 | 0.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.3 | 1.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.3 | 4.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.3 | 7.8 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
| 0.3 | 1.2 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.3 | 0.9 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.3 | 2.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.3 | 1.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.3 | 1.2 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
| 0.3 | 45.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.3 | 1.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.3 | 1.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.3 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.3 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 1.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.3 | 2.6 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.3 | 1.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.3 | 1.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.3 | 2.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.3 | 4.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.3 | 0.9 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.3 | 2.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.3 | 1.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.3 | 0.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.3 | 2.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.3 | 8.9 | GO:0005112 | Notch binding(GO:0005112) |
| 0.3 | 1.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.3 | 0.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.3 | 9.3 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
| 0.3 | 7.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.3 | 2.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.3 | 2.7 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.3 | 1.6 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.3 | 2.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.3 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
| 0.3 | 1.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.3 | 2.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.3 | 17.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.3 | 1.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 1.0 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.3 | 5.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.3 | 3.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.3 | 8.3 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.3 | 2.0 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 1.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.2 | 1.4 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.2 | 6.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.2 | 1.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 5.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.2 | 1.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.2 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 0.7 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.2 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.2 | 2.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 2.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.2 | 2.6 | GO:0031078 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.2 | 2.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.2 | 1.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.2 | 0.4 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.2 | 4.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 1.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 4.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.2 | 2.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 1.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.2 | 5.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 1.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.2 | 2.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 1.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.2 | 1.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 3.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 1.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.2 | 0.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.2 | 5.0 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.2 | 4.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.2 | 0.6 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.2 | 3.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 5.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.2 | 1.0 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.2 | 0.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
| 0.2 | 1.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 1.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.2 | 2.8 | GO:0071949 | FAD binding(GO:0071949) |
| 0.2 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.2 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 11.8 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.2 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.2 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.2 | 6.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 5.2 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.2 | 5.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.2 | 2.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 1.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.2 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.2 | 4.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 1.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 1.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
| 0.2 | 2.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
| 0.2 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.2 | 0.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.2 | 0.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.2 | 0.5 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.2 | 1.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.2 | 0.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.2 | 3.0 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.2 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.2 | 1.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.2 | 2.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 0.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.2 | 1.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.2 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.2 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.2 | 6.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 5.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.2 | 0.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 3.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 4.5 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.2 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 0.3 | GO:0070976 | TIR domain binding(GO:0070976) |
| 0.2 | 0.9 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.2 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.1 | 0.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.1 | 0.6 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.1 | 1.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 1.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 1.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.1 | 1.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 0.5 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.1 | 1.5 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 5.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 4.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 2.4 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 3.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.1 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 2.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 0.5 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
| 0.1 | 8.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 1.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 1.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 0.3 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.1 | 1.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.4 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
| 0.1 | 1.5 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 2.2 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 24.5 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 2.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.3 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.1 | 1.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 1.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 1.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 1.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.1 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 1.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.1 | 0.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 0.7 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.1 | 0.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 3.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.1 | 0.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 1.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 1.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.4 | GO:0048038 | quinone binding(GO:0048038) |
| 0.1 | 0.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.1 | 1.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 2.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.4 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.1 | 1.2 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 0.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) fructose-6-phosphate binding(GO:0070095) |
| 0.1 | 1.9 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 1.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 1.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.1 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 0.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.1 | 0.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.1 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 2.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 11.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.3 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.0 | 1.0 | GO:0019842 | vitamin binding(GO:0019842) |
| 0.0 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 1.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
| 0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.0 | 0.1 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.0 | 0.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.0 | 1.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.0 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 1.7 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.0 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.0 | 1.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.2 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.0 | 1.0 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.0 | 1.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.2 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.1 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.0 | 0.0 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
| 0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
| 0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
| 0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.0 | 0.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
| 0.0 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.0 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.1 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
| 0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.0 | 0.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.0 | 0.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.0 | 0.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.0 | 1.8 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 52.9 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.9 | 8.7 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.7 | 6.7 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.7 | 6.4 | PID_S1P_S1P3_PATHWAY | S1P3 pathway |
| 0.7 | 12.4 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.5 | 10.5 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.5 | 12.5 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.5 | 2.4 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 0.5 | 14.2 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.5 | 56.4 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.5 | 14.5 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.5 | 10.6 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.5 | 11.7 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.4 | 14.6 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.4 | 9.5 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 0.4 | 1.2 | PID_IL23_PATHWAY | IL23-mediated signaling events |
| 0.4 | 5.7 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.4 | 12.2 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 2.1 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.3 | 3.8 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 4.5 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.3 | 2.4 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 18.5 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 3.7 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.3 | 7.2 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 1.6 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.3 | 5.5 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.3 | 44.0 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.3 | 8.5 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.3 | 8.5 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.3 | 17.5 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.3 | 4.3 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.3 | 3.9 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.3 | 1.3 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 4.8 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 7.1 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 13.7 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 2.4 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.2 | 1.5 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 2.0 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
| 0.2 | 1.7 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
| 0.2 | 10.6 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.2 | 10.6 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.2 | 7.5 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.2 | 3.1 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.2 | 0.7 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.2 | 2.6 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.2 | 0.7 | PID_IL27_PATHWAY | IL27-mediated signaling events |
| 0.2 | 3.1 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
| 0.2 | 4.0 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
| 0.2 | 20.4 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 5.5 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
| 0.2 | 1.1 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 1.6 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 27.3 | NABA_MATRISOME_ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.2 | 3.0 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 3.1 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 4.6 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 1.7 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 2.6 | ST_B_CELL_ANTIGEN_RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 0.6 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 8.7 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 5.5 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.1 | 4.0 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 0.3 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 4.0 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.1 | 4.7 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.1 | 1.5 | NABA_CORE_MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.1 | 0.9 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 0.8 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 2.0 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.1 | 1.8 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 6.2 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 0.5 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 1.2 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 1.7 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.1 | 2.4 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.1 | 2.0 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 1.3 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.3 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
| 0.0 | 0.5 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.0 | 1.4 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.1 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 0.3 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.5 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 0.2 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.0 | 0.2 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 0.3 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 1.0 | PID_P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.4 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 16.8 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 2.0 | 12.2 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 1.8 | 23.0 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 1.5 | 1.5 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 1.4 | 18.5 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.3 | 4.0 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.2 | 8.7 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 1.2 | 9.3 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 1.0 | 10.5 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 1.0 | 5.9 | REACTOME_COMPLEMENT_CASCADE | Genes involved in Complement cascade |
| 0.9 | 20.8 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.9 | 64.7 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
| 0.9 | 0.9 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.8 | 5.9 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.8 | 9.6 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.8 | 7.1 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.8 | 5.4 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
| 0.8 | 5.4 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.7 | 19.2 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.7 | 10.1 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.7 | 4.0 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.7 | 6.6 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.6 | 12.8 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.6 | 1.2 | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
| 0.6 | 2.4 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 0.6 | 17.3 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.6 | 7.9 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.6 | 2.2 | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.5 | 6.5 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.5 | 9.6 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.5 | 41.7 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.5 | 6.8 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.5 | 5.5 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.5 | 8.0 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.5 | 5.2 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.5 | 9.9 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.5 | 6.1 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.5 | 1.9 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.5 | 20.5 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.5 | 17.1 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.4 | 4.4 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.4 | 3.5 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.4 | 6.5 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.4 | 7.0 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.4 | 3.1 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
| 0.4 | 10.4 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.4 | 1.2 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.4 | 17.3 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.4 | 21.1 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.4 | 5.7 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.4 | 39.2 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.4 | 23.1 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.4 | 9.1 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.4 | 6.7 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.4 | 10.9 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.3 | 5.2 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 1.3 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.3 | 5.4 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.3 | 3.6 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.3 | 7.8 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.3 | 5.2 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.3 | 1.3 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 0.3 | 2.6 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.3 | 6.0 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.3 | 21.1 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.3 | 5.1 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.3 | 8.4 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.3 | 17.4 | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.3 | 1.5 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.3 | 2.0 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.3 | 3.1 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.3 | 3.3 | REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.3 | 6.0 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.3 | 4.6 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.3 | 4.0 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.3 | 3.4 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 4.4 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.3 | 10.9 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.3 | 12.4 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.3 | 2.3 | REACTOME_PYRIMIDINE_CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.3 | 5.1 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.2 | 5.7 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.2 | 2.5 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 7.2 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.2 | 7.8 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 3.4 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.2 | 0.5 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 6.2 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 5.9 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.2 | 0.5 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.2 | 2.5 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 2.9 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 3.7 | REACTOME_ZINC_TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 1.3 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.2 | 4.6 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.2 | 3.7 | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.2 | 7.6 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.2 | 2.5 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 7.4 | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | Genes involved in Signal transduction by L1 |
| 0.2 | 3.2 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.2 | 1.7 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 0.6 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.2 | 6.8 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 4.6 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 2.0 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.2 | 2.6 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.2 | 3.9 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 13.3 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 0.5 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.2 | 1.5 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 1.9 | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 2.1 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 3.4 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.5 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 3.4 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 1.6 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 5.5 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 2.8 | REACTOME_METABOLISM_OF_NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.1 | 0.9 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 1.2 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 1.4 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 1.6 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 10.8 | REACTOME_METABOLISM_OF_CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.1 | 0.6 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 3.4 | REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.1 | 1.3 | REACTOME_POL_SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 0.8 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 1.2 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 1.5 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 1.0 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 1.4 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 2.1 | REACTOME_TRNA_AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.1 | 1.8 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.8 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.1 | 0.6 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 1.3 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 3.0 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.8 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 0.7 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 2.1 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 0.7 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 1.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 2.6 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 0.7 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 0.3 | REACTOME_P75NTR_SIGNALS_VIA_NFKB | Genes involved in p75NTR signals via NF-kB |
| 0.0 | 0.8 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 0.0 | 0.3 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
| 0.0 | 0.5 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 1.3 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.3 | REACTOME_INTEGRATION_OF_PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 1.3 | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.0 | 0.2 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.2 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 0.5 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 0.2 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.0 | 0.1 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 1.2 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.1 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 0.1 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 0.1 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.3 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 0.1 | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.0 | 0.3 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
